Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2022 | 06-2022 | 04-2022 | 03-2022 | 01-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -662 | N/A | -404 | N/A |
| Other Working Capital | 522 | 522 | 285 | 285 | 0 |
| Other Operating Activity | -155 | -155 | -42 | -41 | 0 |
| Operating Cash Flow | $368 | $-294 | $244 | $-160 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $0 | $N/A | $0 | $N/A | $0 |
| Beginning Cash Position | N/A | 1,069 | N/A | 1,069 | N/A |
| End Cash Position | N/A | 775 | N/A | 910 | N/A |
| Net Cash Flow | $368 | $-294 | $244 | $-160 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 368 | -294 | 244 | -160 | N/A |
| Free Cash Flow | 368 | -294 | 244 | -160 | 0 |